CU20140121A7 - USO INTRAUTERINO DE 18–METIL–15ß,16ß–METILEN–19–NOR–20–ESPIROX–4–EN–3–ONAS, SISTEMAS INTRAUTERINOS QUE CONTIENEN 18–METIL–15ß,16ß–METILEN–19–NOR–20–ESPIROX–4–EN–3–ONAS, ASÍ COMO SU USO EN LA ANTICONCEPCIÓN Y TERAPIA GINECOLÓGICA - Google Patents

USO INTRAUTERINO DE 18–METIL–15ß,16ß–METILEN–19–NOR–20–ESPIROX–4–EN–3–ONAS, SISTEMAS INTRAUTERINOS QUE CONTIENEN 18–METIL–15ß,16ß–METILEN–19–NOR–20–ESPIROX–4–EN–3–ONAS, ASÍ COMO SU USO EN LA ANTICONCEPCIÓN Y TERAPIA GINECOLÓGICA

Info

Publication number
CU20140121A7
CU20140121A7 CU2014000121A CU20140121A CU20140121A7 CU 20140121 A7 CU20140121 A7 CU 20140121A7 CU 2014000121 A CU2014000121 A CU 2014000121A CU 20140121 A CU20140121 A CU 20140121A CU 20140121 A7 CU20140121 A7 CU 20140121A7
Authority
CU
Cuba
Prior art keywords
metilen
espirox
metil
intrauterine
well
Prior art date
Application number
CU2014000121A
Other languages
English (en)
Inventor
Norbert Schmees
Dr Lars Rose
Tuula Valo
Katja Prelle
Reinhard Nubbemeyer
Henriikka Korolainen
Harri Jukarainen
Original Assignee
Bayer Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48142002&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CU20140121(A7) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Pharma AG filed Critical Bayer Pharma AG
Publication of CU20140121A7 publication Critical patent/CU20140121A7/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0039—Devices retained in the uterus for a prolonged period, e.g. intrauterine devices for contraception
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Reproductive Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención describe el uso intrauterino de 18–metil–15ß,16ß–metilen–19–nor–20–espirox–4–en–3–onas de la fórmula general (1) fórmula (1) en la anticoncepción la terapia ginecológica, así como un sistema intrauterino que contiene compuestos de la fórmula 1.
CU2014000121A 2012-04-23 2014-10-23 USO INTRAUTERINO DE 18–METIL–15ß,16ß–METILEN–19–NOR–20–ESPIROX–4–EN–3–ONAS, SISTEMAS INTRAUTERINOS QUE CONTIENEN 18–METIL–15ß,16ß–METILEN–19–NOR–20–ESPIROX–4–EN–3–ONAS, ASÍ COMO SU USO EN LA ANTICONCEPCIÓN Y TERAPIA GINECOLÓGICA CU20140121A7 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102012206652 2012-04-23
PCT/EP2013/058220 WO2013160213A1 (de) 2012-04-23 2013-04-19 INTRAUTERINE ANWENDUNG VON 18-METHYL-15ß,16ß-METHYLEN-19-NOR-20-SPIROX-4-EN-3-ONEN, INTRAUTERINE SYSTEME ENTHALTEND 18-METHYL-15ß,16ß-METHYLEN-19-NOR-20-SPIROX-4-EN-3-ONE, SOWIE DEREN VERWENDUNG IN DER KONTRAZEPTION UND GYNÄKOLOGISCHEN THERAPIE

Publications (1)

Publication Number Publication Date
CU20140121A7 true CU20140121A7 (es) 2014-12-26

Family

ID=48142002

Family Applications (1)

Application Number Title Priority Date Filing Date
CU2014000121A CU20140121A7 (es) 2012-04-23 2014-10-23 USO INTRAUTERINO DE 18–METIL–15ß,16ß–METILEN–19–NOR–20–ESPIROX–4–EN–3–ONAS, SISTEMAS INTRAUTERINOS QUE CONTIENEN 18–METIL–15ß,16ß–METILEN–19–NOR–20–ESPIROX–4–EN–3–ONAS, ASÍ COMO SU USO EN LA ANTICONCEPCIÓN Y TERAPIA GINECOLÓGICA

Country Status (28)

Country Link
US (1) US20150065472A1 (es)
EP (1) EP2841074A1 (es)
JP (1) JP2015514791A (es)
KR (1) KR20150004807A (es)
CN (1) CN104254333A (es)
AR (1) AR090799A1 (es)
AU (1) AU2013254840A1 (es)
BR (1) BR112014026193A2 (es)
CA (1) CA2871003A1 (es)
CL (1) CL2014002836A1 (es)
CO (1) CO7111255A2 (es)
CR (1) CR20140490A (es)
CU (1) CU20140121A7 (es)
DO (1) DOP2014000241A (es)
EA (1) EA201491922A1 (es)
EC (1) ECSP14024250A (es)
HK (1) HK1205000A1 (es)
IL (1) IL235095A0 (es)
IN (1) IN2014DN07839A (es)
MA (1) MA37444A1 (es)
MX (1) MX2014012849A (es)
PE (1) PE20142438A1 (es)
PH (1) PH12014502372A1 (es)
SG (1) SG11201406582XA (es)
TN (1) TN2014000444A1 (es)
TW (1) TW201350122A (es)
UY (1) UY34758A (es)
WO (1) WO2013160213A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015055789A1 (en) * 2013-10-17 2015-04-23 Bayer Pharma Aktiengesellschaft INTRAVAGINAL USE OF 18-METHYL-15ß,16ß-METHYLENE-19-NOR-20-SPIROX-4-EN-3-ONES, INTRAVAGINAL RINGS COMPRISING 18-METHYL-15ß,16ß-METHYLENE-19-NOR-20-SPIROX-4-EN-3-ONES, AND USE THEREOF IN CONTRACEPTION

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH30867A (en) 1992-07-31 1997-12-09 Leiras Oy Method and equipment for installing a medicine capsule on a support.
FI90627C (fi) 1992-07-31 1994-03-10 Leiras Oy Laitteisto lääkeainesauvan varustamiseksi vaipalla
FI107339B (fi) 1998-06-30 2001-07-13 Leiras Oy Lääkeaineiden läpäisynopeutta säätävä kalvo tai matriisi
US6056976A (en) 1998-11-12 2000-05-02 Leiras Oy Elastomer, its preparation and use
DE60113809T2 (de) * 2000-01-18 2006-06-22 Schering Ag Pharmazeutische kombination aus mikronisiertem drospirenon und einen estrogen für die hormonersatztherapie
RU2403046C2 (ru) * 2003-07-16 2010-11-10 Тева Вимен'С Хелс, Инк. Способы гормонального лечения с применением контрацептивных режимов с непрерывным введением эстрогена
DE102006030416A1 (de) * 2006-06-29 2008-01-03 Bayer Schering Pharma Ag 18-Methyl-19-nor-androst-4-en-17,17-spiroether (18-Methyl-19-nor-20-spirox-4-en-3-one) sowie diese enthaltende pharmazeutische Präparate
DE102007011105A1 (de) * 2007-03-02 2008-09-04 Bayer Schering Pharma Aktiengesellschaft Mineralcorticoid-Rezeptor-Antagonisten zur Behandlung von Endometriose
DE102007063496A1 (de) * 2007-12-29 2009-07-02 Bayer Schering Pharma Aktiengesellschaft 15,16-Methylen-17-(1'-propenyl)-17-3'-oxidoestra-4-en-3-on-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007063495A1 (de) * 2007-12-29 2009-09-17 Bayer Schering Pharma Aktiengesellschaft 19-Nor-Steroidderivate mit einer 15α,16α-Methylengruppe und einem gesättigten 17,17-Spirolactonring, deren Verwendung sowie diese Derivate enthaltende Arzneimittel
EP2140860A1 (en) * 2008-07-03 2010-01-06 Bayer Schering Pharma Oy An improved method of contraception
PT2012063262W (pt) * 2010-11-08 2015-06-11 Hll Lifecare Ltd Um novo dispositivo intra-uterino com libertação controlada de cobre

Also Published As

Publication number Publication date
HK1205000A1 (en) 2015-12-11
TN2014000444A1 (en) 2016-03-30
AU2013254840A1 (en) 2014-11-06
WO2013160213A1 (de) 2013-10-31
IL235095A0 (en) 2014-12-31
MX2014012849A (es) 2015-02-05
BR112014026193A2 (pt) 2017-06-27
MA37444A1 (fr) 2016-11-30
SG11201406582XA (en) 2014-11-27
CN104254333A (zh) 2014-12-31
CO7111255A2 (es) 2014-11-10
JP2015514791A (ja) 2015-05-21
CR20140490A (es) 2014-11-17
DOP2014000241A (es) 2014-12-31
IN2014DN07839A (es) 2015-04-24
CL2014002836A1 (es) 2015-03-13
CA2871003A1 (en) 2013-10-31
PH12014502372A1 (en) 2015-01-26
EP2841074A1 (de) 2015-03-04
AR090799A1 (es) 2014-12-10
UY34758A (es) 2013-11-29
TW201350122A (zh) 2013-12-16
PE20142438A1 (es) 2015-02-01
US20150065472A1 (en) 2015-03-05
EA201491922A1 (ru) 2015-04-30
KR20150004807A (ko) 2015-01-13
ECSP14024250A (es) 2015-12-31

Similar Documents

Publication Publication Date Title
CL2016002735A1 (es) Compuestos de imidazo[4,5-c]quinolin-2-ona y su uso para tratar cáncer
CR20150462A (es) Inhibidores de erk y sus usos
CL2015002301A1 (es) Acido 2-aza-biciclo[2.2.1]heptano-3-carboxílico (bencil-ciano-metil)-amidas sustituidas inhibidores de catepsina c.
CR20140576A (es) Sintesis de compuestos heterociclicos
UY34632A (es) Compuestos de oxazolidin- 2- ona y usos de los mismos
UY35500A (es) Indazoles sustituidos con heteroarilo
CR20150247A (es) Anticuerpos de antihemaglutinina y métodos de uso
CO6741157A2 (es) Composiciones plaguicidas y procesos relacionados con dichas composiciones
UY36737A (es) 3-amino-1,5,6,7-tetrahidro-4h-indol-4-onas
BR112015030308A2 (pt) antagonistas de progesterona de imidazolila
EA201591196A1 (ru) Композиции и способы для трансдермальной доставки гормонов и других лекарственных средств
MX2015011837A (es) Co-cristale de pirimetanil y tetracarboximida de ditiina seleccionada.
CR20160070A (es) Compuestos de triazolopiridina, composiciones y métodos de uso de los mismos
CU20160051A7 (es) Sistema de administración intrauterina
CL2015002113A1 (es) Compuestos de azetidinloxifenilpirrolidina
CU20140121A7 (es) USO INTRAUTERINO DE 18–METIL–15ß,16ß–METILEN–19–NOR–20–ESPIROX–4–EN–3–ONAS, SISTEMAS INTRAUTERINOS QUE CONTIENEN 18–METIL–15ß,16ß–METILEN–19–NOR–20–ESPIROX–4–EN–3–ONAS, ASÍ COMO SU USO EN LA ANTICONCEPCIÓN Y TERAPIA GINECOLÓGICA
BR102014007923A8 (pt) sistema nanoestruturado polimérico e seu uso
CR20140489A (es) Uso de 18-metil-15b, 16b-metilen-19-nor-20-espirox-4-en-3-onas en el tratamiento de menorragia, y sistemas intrauterinos que comprenden 18-metil-15b, 16b-metilen-19-nor-20-espirox-4-en-3-onas para el tratamiento de t
RU2013142538A (ru) Ароматические полиэфирсульфонкетоны
UY35789A (es) USO INTRAVAGINAL DE LAS 18-METIL-15ß, 16ß-METILEN-19-NOR-20-ESPIROX-4-EN-3-ONAS, ANILLOS INTRAVAGIN ALES QUE COMPRENDEN 18-METIL-15ß,16ß-METILEN-19-NOR-20-ESPIROX-4-EN-3-ONAS Y SU USO EN LA ANTICONCE PCIÓN
ITRE20130091A1 (it) Sistema per l'installazione di antenne
AR098060A1 (es) Sistema de administración intrauterina
RU2013145422A (ru) Производное 5-оксипиримидина, обладающее противоопухолевой активностью